首页 | 本学科首页   官方微博 | 高级检索  
检索        


Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week,randomized, placebo-controlled,phase II study
Authors:Yutaka Seino  Takashi Sasaki  Atsushi Fukatsu  Yoshishige Samukawa
Institution:1. Kansai Electric Power Hospital OsakaJapan;2. Jikei University School of Medicine TokyoJapan;3. Yachiyo Hospital AichiJapan;4. Taisho Pharmaceutical Co. Ltd TokyoJapan
Abstract:
Keywords:Japanese  Luseogliflozin  Monotherapy  Phase II clinical study  Placebo  Sodium glucose cotransporter 2 (SGLT2) inhibitor  Type 2 diabetes mellitus
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号